Abstract:Background: Cigarette smoking is an important environmental risk factor for cardiovascular events of hypertension (HTN). Existing studies have provided evidence supporting altered gut microbiota by cigarette smoking, especially in hypertensive patients. Metabolic biomarkers play a central role in the functional potentials of the gut microbiome but are poorly characterized in hypertensive smokers. To explore whether serum metabolomics signatures and compositions of HTN patients were varied in smokers, and investigate their connecting relationship to gut microbiota, the serum metabolites were examined in untreated hypertensive patients using untargeted liquid chromatography-mass spectrometry (LC/MS) analysis. Results: A dramatic difference and clear separation in community features of circulating metabolomics members were seen in smoking HTN patients compared with the non-smoking controls, according to partial least squares discrimination analysis (PLS-DA) and orthogonal partial least squares discrimination analysis (OPLS-DA). Serum metabolic profiles and compositions of smoking patients with HTN were significantly distinct from the controls, and were characterized by enrichment of 12-HETE, 7-Ketodeoxycholic acid, Serotonin, N-Stearoyl tyrosine and Deoxycholic acid glycine conjugate, and the depletion of Tetradecanedioic acid, Hippuric acid, Glyceric acid, 20-Hydroxyeicosatetraenoic acid, Phenylpyruvic acid and Capric acid. Additionally, the metabolome displayed prominent functional signatures, with a majority proportion of the metabolites identified to be discriminating between groups distributed in Starch and sucrose metabolism, Caffeine metabolism, Pyruvate metabolism, Glycine, serine and threonine metabolism, and Phenylalanine metabolic pathways. Furthermore, the observation of alterations in metabolites associated with intestinal microbial taxonomy indicated that these metabolic members might mediate the effects of gut microbiome on the smoking host. Indeed, the metabolites specific to smoking HTNs were strongly organized into co-abundance networks, interacting with an array of clinical parameters, including uric acid (UA), low-denstiy lipoprotein cholesterol (LDLC) and smoking index. Conclusions: In conclusion, we demonstrated disparate circulating blood metabolome composition and functional potentials in hypertensive smokers, showing a linkage between specific metabolites in blood and the gut microbiome.

Potential Roles of Cigarette Smoking on Gut Microbiota Profile among Chinese Men

Association of Cigarette Smoking with Oral Bacterial Microbiota and Cardiometabolic Health in Chinese Adults

Gut Microbiota Partially Mediates the Effects of Fine Particulate Matter on Type 2 Diabetes: Evidence from a Population-Based Epidemiological Study.

The effects of cigarettes and alcohol on intestinal microbiota in healthy men

Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two independent cohorts with sibling comparison analyses

Association Between Oral Microbiota and Cigarette Smoking in the Chinese Population

Case-only study of interactions between metabolic enzymes and smoking in colorectal cancer

Active Smoking Induces Aberrations in Digestive Tract Microbiota of Rats

When smoke meets gut: deciphering the interactions between tobacco smoking and gut microbiota in disease development

Effect of Cigarette Smoke on Gut Microbiota: State of Knowledge

Association of cigarette smoking with risk of colorectal cancer subtypes classified by gut microbiota

[Mediation of Abdominal Obesity on the Association Between Cigarette Smoking and Β-Cell Function].

Cross-talks between gut microbiota and tobacco smoking: a two-sample Mendelian randomization study

Heme Metabolism Mediates the Effects of Smoking on Gut Microbiome.

Tobacco Advertising, Anti-Tobacco Information Exposure, Environmental Smoking Restrictions, and Unassisted Smoking Cessation among Chinese Male Smokers: A Population-Based Study

Smoking-induced microbial dysbiosis in health and disease

Targeting Lung–Gut Axis for Regulating Pollution Particle–Mediated Inflammation and Metabolic Disorders

Untargeted metabolomics unravel serum metabolic alterations in smokers with hypertension

Effects of Smoking on the Gut Microbiota in Individuals with Type 2 Diabetes Mellitus

Can Smoking Cause Differences in Urine Microbiome in Male Patients with Bladder Cancer? A Retrospective Study.

Gender-Specific Association Between Tobacco Smoking and Central Obesity among 0.5 Million Chinese People: the China Kadoorie Biobank Study